EP4104824
SAMSETNING TIL NOTKUNAR Í AÐFERÐ TIL AÐ MEÐHÖNDLA OFFITU OG OFÞYNGD HJÁ SJÚKLINGUM MEÐ MIKLA ÁHÆTTU Á HJARTA- OG ÆÐASJÚKDÓMUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.6.2013EP published:
21.5.2025EP application number:
22170364.8
EP translation filed:
7.8.2025Grant published:
15.9.2025EPO information:
European Patent Register
Max expiry date:
4.6.2033Expiry date:
4.6.2026Next due date:
30.6.2026
Title in English:
COMPOSITION FOR USE IN A METHOD OF TREATING OVERWEIGHT AND OBESITY IN PATIENTS WITH HIGH CARDIOVASCULAR RISKLanguage of the patent:
English
Timeline
Today
5.6.2013EP application
21.5.2025EP Publication
7.8.2025Translation submitted
15.9.2025Registration published
4.6.2026Expires
Owner
Name:
Nalpropion Pharmaceuticals LLCAddress:
155 Franklin Rd, Suite 450, Brentwood, TN 37027, US
Inventor
Name:
KLASSEN, PrestonAddress:
La Jolla, 92037, US
Name:
TAYLOR, KristinAddress:
San Diego, 92127, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201261656451 PDate:
6.6.2012Country:
US
Classification
Categories:
A61K 31/137, A61K 31/485, A61P 3/04, A61P 9/00, A61P 9/04, A61P 9/10, A61K 9/20, G01G 19/414, G09B 5/06, G09B 19/00, G16H 20/10
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 1.9.2025
Expires: 4.6.2026
Payer: Zacco Denmark A/S